Anti-™9SF1 monoclonal antibody

Pre-made anti-™9SF1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™9SF1/™9SF1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1927-Ab-1/ GM-Tg-hg-IP1927-Ab-2Anti-Human ™9SF1 monoclonal antibodyHuman
GM-Tg-rg-IP1927-Ab-1/ GM-Tg-rg-IP1927-Ab-2Anti-Rat ™9SF1 monoclonal antibodyRat
GM-Tg-mg-IP1927-Ab-1/ GM-Tg-mg-IP1927-Ab-2Anti-Mouse ™9SF1 monoclonal antibodyMouse
GM-Tg-cynog-IP1927-Ab-1/ GM-Tg-cynog-IP1927-Ab-2Anti-Cynomolgus/ Rhesus macaque ™9SF1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1927-Ab-1/ GM-Tg-felg-IP1927-Ab-2Anti-Feline ™9SF1 monoclonal antibodyFeline
GM-Tg-cang-IP1927-Ab-1/ GM-Tg-cang-IP1927-Ab-2Anti-Canine ™9SF1 monoclonal antibodyCanine
GM-Tg-bovg-IP1927-Ab-1/ GM-Tg-bovg-IP1927-Ab-2Anti-Bovine ™9SF1 monoclonal antibodyBovine
GM-Tg-equg-IP1927-Ab-1/ GM-Tg-equg-IP1927-Ab-2Anti-Equine ™9SF1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1927-Ab-1/ GM-Tg-hg-IP1927-Ab-2; GM-Tg-rg-IP1927-Ab-1/ GM-Tg-rg-IP1927-Ab-2;
GM-Tg-mg-IP1927-Ab-1/ GM-Tg-mg-IP1927-Ab-2; GM-Tg-cynog-IP1927-Ab-1/ GM-Tg-cynog-IP1927-Ab-2;
GM-Tg-felg-IP1927-Ab-1/ GM-Tg-felg-IP1927-Ab-2; GM-Tg-cang-IP1927-Ab-1/ GM-Tg-cang-IP1927-Ab-2;
GM-Tg-bovg-IP1927-Ab-1/ GM-Tg-bovg-IP1927-Ab-2; GM-Tg-equg-IP1927-Ab-1/ GM-Tg-equg-IP1927-Ab-2
Products NameAnti-™9SF1 monoclonal antibody
Formatmab
Target Name™9SF1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™9SF1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1927-Ag-1Recombinant multi-species ™9S1/ ™9SF1/ HMP70 protein


    Target information

    Target IDGM-IP1927
    Target Name™9SF1
    Gene ID10548,74140,361043,715472,480261,101101224,539478,100051449
    Gene Symbol and Synonyms1200014D02Rik,HMP70,MP70,™9SF1
    Uniprot AccessionO15321,Q66HF2,A4IFE9
    Uniprot Entry Name™9S1_HUMAN,™9S1_RAT,™9S1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000100926
    Target ClassificationN/A

    The target: ™9SF1, gene name: ™9SF1, also named as HMP70, MP70. Predicted to be involved in protein localization to membrane. Predicted to be located in autophagosome membrane; cytoplasmic vesicle; and lysosomal membrane. Predicted to be integral component of membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.